Firstly, the single-center design, relatively small sample size, and inability to conduct subgroup analyses based on pathogen types (e.g., bacterial, viral, fungal infections) may constrain the generalizability of findings and limit insights into pathogen-specific heterogeneity in GSDMD-NETs axis activation among sepsis patients. The gene discussed is GSDMD; the disease is fungal infectious disease.